Quantification of genotype 4 serum samples: Impact of hepatitis C virus genetic variability†
Potential conflict of interest: Dr. Marcellin received grants, is on the speakers' bureau of, and advises Roche, Schering-Plough, and Gilead. He also advises and is on the speakers' bureau of Bristol-Myers Squibb, Novartis, and Intermune. He advises Vertex, Pharmaseet, Tibotec, Merck Sharp & Dohme, Boehringer, Biolex, and Zymogenetics.
No abstract is available for this article.